Table 3. Satisfaction with Life group secondary outcomes baseline (T1) to 2-year post-intervention (T5) (N = 39).
| SCS Severity | 95% CI | HPLP | 95% CI | PSS | 95% CI | ||||
|---|---|---|---|---|---|---|---|---|---|
| Estimate (SE) | LB | UB | Estimate (SE) | LB | UB | Estimate (SE) | LB | UB | |
| Intercept | 19.63 (3.66)*** | 12.39 | 26.86 | 132.75 (5.58)*** | 121.71 | 143.79 | 31.06 (1.37)*** | 28.35 | 33.78 |
| SWL Group | 4.85 (4.76) | −4.57 | 14.28 | −3.31 (7.26) | −17.69 | 11.06 | 1.98 (1.79) | −1.56 | 5.52 |
| Time 2 | −1.90 (5.73) | −13.24 | 9.24 | 0.98 (8.73) | −16.31 | 18.26 | −0.70 (2.15) | −4.95 | 3.56 |
| Time 3 | −4.31 (6.31) | −16.79 | 8.17 | −5.72 (9.64) | −24.80 | 13.36 | 0.81 (2.38) | −3.89 | 5.51 |
| Time 4 | −8.38 (6.94) | −22.11 | 5.35 | 9.10 (10.51) | −11.69 | 29.89 | 0.44 (2.63) | −4.76 | 5.64 |
| Time 5 | −5.43 (7.15) | −19.62 | 8.75 | −16.88 (11.82) | −40.32 | 6.55 | −6.24 (2.81)* | −11.80 | −0.68 |
| SWL Group × Time | |||||||||
| High Time 2 | −6.17 (7.35) | −20.72 | 8.37 | 17.90 (11.02) | −4.27 | 40.08 | −0.01 (2.76) | −5.47 | 5.45 |
| High Time 3 | 2.89 (7.90) | −12.73 | 18.52 | 3.78 (12.07) | −20.11 | 27.68 | −4.48 (2.97) | −10.37 | 1.40 |
| High Time 4 | 2.23 (8.44) | −14.46 | 18.93 | −0.46 (12.77) | −25.73 | 24.81 | −1.49 (3.20) | −7.82 | 4.84 |
| High Time 5 | 2.76 (8.76) | −14.61 | 20.14 | 11.43 (14.63) | −17.58 | 40.44 | 3.93 (3.45) | −2.91 | 10.77 |
| AR(var) | 214.09 (26.97)** | 167.26 | 274.04 | 497.81 (63.62)** | 387.51 | 639.51 | 30.15 (3.75)** | 23.62 | 38.49 |
| AR(rho) | 0.15 (0.11) | −0.06 | 0.35 | −0.20 (0.12) | −0.42 | 0.04 | 0.01 (0.10) | −0.19 | 0.21 |
Referent Low Satisfaction with Life Group and Baseline Time 1.
SWL, Satisfaction with Life; 95% CI, 95% confidence interval; LB, lower bound; UB, upper bound; AR(var), residual variance of dependent variable at each time point; AR(rho), autocorrelation.
*P < 0.05, **P < 0.01, *** P < 0.001.